These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 352667)

  • 1. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Aug; 16(2):97-114. PubMed ID: 352667
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical and biological studies on indomethacin, sulindac and their analogs.
    Shen TY; Winter CA
    Adv Drug Res; 1977; 12():90-245. PubMed ID: 343530
    [No Abstract]   [Full Text] [Related]  

  • 3. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.
    Sorkin EM; Brogden RN
    Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic polyarthritis with Sulindac].
    Vetter G; Picha B
    MMW Munch Med Wochenschr; 1977 Oct; 119(42):1369-70. PubMed ID: 412071
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulindac. Trials of a new anti-inflammatory drug.
    Huskisson EC; Scott J
    Ann Rheum Dis; 1978 Feb; 37(1):89-92. PubMed ID: 343728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac.
    Lancet; 1977 Feb; 1(8009):462-3. PubMed ID: 65569
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of sulindac and aspirin in rheumatoid arthritis.
    Reynolds PM; Rhymer AR; MacLeod MM; Buchanan WW
    Curr Med Res Opin; 1977; 4(7):485-91. PubMed ID: 321183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Jun; 15(6):429-50. PubMed ID: 350558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)].
    Fasching U; Eberl R
    Wien Klin Wochenschr Suppl; 1976; 59():1-10. PubMed ID: 136815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cooperative clinical study of Sulindac in arthrosis (hip joint and knee) in general medicine].
    Delcambre B
    Lille Med; 1977 Apr; 22(4 Suppl 1):266-8. PubMed ID: 327175
    [No Abstract]   [Full Text] [Related]  

  • 11. [MK-231 (Sulindac) in the treatment of rheumatoid arthritis (author's transl)].
    Bachmann F; Hartl W
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1772-5. PubMed ID: 336322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Open clinical therapeutic trial using Clinoril in gonarthroses].
    Truhlár P; Machácek P
    Fysiatr Revmatol Vestn; 1978 Jun; 56(3):146-8. PubMed ID: 352880
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoprofen. A survey of current publications.
    Fossgreen J
    Scand J Rheumatol Suppl; 1976; 1976(0):7-32. PubMed ID: 136040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulindac in arthrosis and rheumatoid arthritis].
    Baumgartner H
    Verh Dtsch Ges Rheumatol; 1978; 5():264-6. PubMed ID: 706677
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis.
    Fumagalli M; Cunietti E; Vaiani G; Monti M; Ferrari F; Gandini R
    Clin Ther; 1986; 8(3):292-300. PubMed ID: 3521858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night medication in rheumatoid arthritis. III. the use of sulindac.
    Sharma BK; Haslock I
    Curr Med Res Opin; 1978; 5(6):472-5. PubMed ID: 350499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Dec; 18(6):417-38. PubMed ID: 391529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.